z-logo
open-access-imgOpen Access
Benefits of Long-Term Continuation of Low-Dose Methimazole Therapy in the Prevention of Recurrent Hyperthyroidism in Graves’ Hyperthyroid Patients: A Randomized Prospective Controlled Study
Author(s) -
Raweewan Lertwattanarak,
Tada Kunavisarut,
Sutin Sriussadaporn
Publication year - 2022
Publication title -
international journal of endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.875
H-Index - 60
eISSN - 1687-8345
pISSN - 1687-8337
DOI - 10.1155/2022/1705740
Subject(s) - medicine , euthyroid , adverse effect , randomized controlled trial , graves' disease , methimazole , regimen , randomization , prospective cohort study , antithyroid agent , thyroid function , radioiodine therapy , gastroenterology , pediatrics , thyroid , thyroid cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom